SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eulàlia Genescà, Jordi Ribera, Josep-Maria Ribera, Acute lymphoblastic leukemia of T progenitors: From biology to clinics, Medicina Clínica (English Edition), 2015, 144, 5, 223

    CrossRef

  2. 2
    Caroline Le Jeune, Xavier Thomas, Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia, European Journal of Haematology, 2015, 94, 2
  3. 3
    Jing Ai, Anjali Advani, Current status of antibody therapy in ALL, British Journal of Haematology, 2015, 168, 4
  4. 4
    Viswanath Reddy Belum, Courtney Washington, Christine A. Pratilas, Vincent Sibaud, Franck Boralevi, Mario E. Lacouture, Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis, Pediatric Blood & Cancer, 2015, 62, 5
  5. 5
    David R. Shook, Brandon M. Triplett, Paul W. Eldridge, Guolian Kang, Ashok Srinivasan, Wing Leung, Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability, Pediatric Blood & Cancer, 2015, 62, 4
  6. 6
    Weili Sun, Paul S. Gaynon, Richard Sposto, Alan S. Wayne, Improving access to novel agents for childhood leukemia, Cancer, 2015, 121, 12
  7. 7
    Eulàlia Genescà, Jordi Ribera, Josep-Maria Ribera, Leucemia aguda linfoblástica de precursores T: de la biología a la clínica, Medicina Clínica, 2015, 144, 5, 223

    CrossRef

  8. 8
    E. Jabbour, S. O'Brien, F. Ravandi, H. Kantarjian, Monoclonal antibodies in acute lymphoblastic leukemia, Blood, 2015, 125, 26, 4010

    CrossRef

  9. 9
    Xavier Thomas, Novel approaches to pediatric leukemia treatment, Expert Review of Anticancer Therapy, 2015, 15, 7, 811

    CrossRef

  10. 10
    J S McCune, P Jacobson, A Wiseman, O Militano, Optimizing drug therapy in pediatric SCT: Focus on pharmacokinetics, Bone Marrow Transplantation, 2015, 50, 2, 165

    CrossRef

  11. 11
    Helena Edlund, Johanna Melin, Zinnia P. Parra-Guillen, Charlotte Kloft, Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Relationships of Monoclonal Antibodies in Children, Clinical Pharmacokinetics, 2015, 54, 1, 35

    CrossRef

  12. 12
    Aditi Vedi, David S. Ziegler, Antibody Therapy for Pediatric Leukemia, Frontiers in Oncology, 2014, 4,

    CrossRef

  13. 13
    V Krishnan, A K Rajasekaran, Clinical Nanomedicine: A Solution to the Chemotherapy Conundrum in Pediatric Leukemia Therapy, Clinical Pharmacology & Therapeutics, 2014, 95, 2
  14. 14
    Shira Dinner, Daniel Lee, Michaela Liedtke, Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia, Leukemia & Lymphoma, 2014, 55, 8, 1715

    CrossRef

  15. 15
    Jessica Hochberg, Nader Kim El-Mallawany, Mitchell S. Cairo, Humoral and Cellular Immunotherapy in ALL in Children, Adolescents, and Young Adults, Clinical Lymphoma Myeloma and Leukemia, 2014, 14, S6

    CrossRef

  16. 16
    Federica Saletta, Carol Wadham, David S. Ziegler, Glenn M. Marshall, Michelle Haber, Geoffrey McCowage, Murray D. Norris, Jennifer A. Byrne, Molecular profiling of childhood cancer: Biomarkers and novel therapies, BBA Clinical, 2014, 1, 59

    CrossRef

  17. 17
    Annelies van Vuren, Friederike Meyer-Wentrup, New targets for antibody therapy of pediatric B cell lymphomas, Pediatric Blood & Cancer, 2014, 61, 12
  18. 18
    Craig A. Portell, Anjali S. Advani, Novel targeted therapies in acute lymphoblastic leukemia, Leukemia & Lymphoma, 2014, 55, 4, 737

    CrossRef

  19. 19
    Michael S. Mathisen, Hagop Kantarjian, Deborah Thomas, Susan O’Brien, Elias Jabbour, Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure rates, Leukemia & Lymphoma, 2013, 54, 12, 2592

    CrossRef

  20. 20
    Naval Daver, Susan O’Brien, Novel Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia – A Focus on Emerging Monoclonal Antibodies, Current Hematologic Malignancy Reports, 2013, 8, 2, 123

    CrossRef

  21. 21
    Keith J. August, Aru Narendran, Kathleen A. Neville, Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions, Drugs, 2013, 73, 5, 439

    CrossRef

  22. 22
    Deepa Bhojwani, Ching-Hon Pui, Relapsed childhood acute lymphoblastic leukaemia, The Lancet Oncology, 2013, 14, 6, e205

    CrossRef

  23. 23
    Dieter Hoelzer, Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia, Current Opinion in Oncology, 2013, 25, 6, 701

    CrossRef

  24. 24
    Osmond J D’Cruz, Fatih M Uckun, Monoclonal Antibodies in Oncology, 2013,

    CrossRef

  25. 25
    Craig A. Portell, Anjali S. Advani, Antibody Therapy for Acute Lymphoblastic Leukemia, Current Hematologic Malignancy Reports, 2012, 7, 2, 153

    CrossRef

  26. 26
    Anthony Mato, Tatyana Feldman, Joshua Richter, David S. Siegel, Andre Goy, Liquid Tumors in the Elderly, Clinics in Geriatric Medicine, 2012, 28, 1, 115

    CrossRef

  27. 27
    Neerav Shukla, Rachel Kobos, Thomas Renaud, Julie Teruya-Feldstein, Anita Price, Linda McAllister-Lucas, Peter Steinherz, Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab, Cancer, 2012, 118, 15
  28. 28
    Matthew Barth, Elizabeth Raetz, Mitchell S. Cairo, The future role of monoclonal antibody therapy in childhood acute leukaemias, British Journal of Haematology, 2012, 159, 1
  29. 29
    Dan Douer, What is the impact, present and future, of novel targeted agents in acute lymphoblastic leukemia?, Best Practice & Research Clinical Haematology, 2012, 25, 4, 453

    CrossRef

  30. 30
    S Rafiq, C Cheney, X Mo, D Jarjoura, N Muthusamy, J C Byrd, XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells, Leukemia, 2012, 26, 7, 1720

    CrossRef

  31. 31
    M C Béné, T Nebe, P Bettelheim, B Buldini, H Bumbea, W Kern, F Lacombe, P Lemez, I Marinov, E Matutes, M Maynadié, U Oelschlagel, A Orfao, R Schabath, M Solenthaler, G Tschurtschenthaler, A M Vladareanu, G Zini, G C Faure, A Porwit, Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10, Leukemia, 2011, 25, 4, 567

    CrossRef

  32. 32
    B. A. Nijmeijer, M. L. J. van Schie, C. J. M. Halkes, M. Griffioen, R. Willemze, J. H. F. Falkenburg, A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL, Blood, 2010, 116, 26, 5930

    CrossRef

  33. 33
    Jacyntha Sterling, Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy, Hospital Pharmacy, 2010, 45, 2, 167

    CrossRef

  34. 34
    Rong Shi, Hartmut Derendorf, Pediatric Dosing and Body Size in Biotherapeutics, Pharmaceutics, 2010, 2, 4, 389

    CrossRef

  35. 35
    Alisa B. Lee-Sherick, Rachel M. A. Linger, Lia Gore, Amy K. Keating, Douglas K. Graham, Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development, British Journal of Haematology, 2010, 151, 4
  36. 36
    D. I. Marks, Treating the "Older" Adult With Acute Lymphoblastic Leukemia, Hematology, 2010, 2010, 1, 13

    CrossRef

  37. 37
    Nitin Jain, Susan O'Brien,, Ravandi-Kashani Farhad, Targeted Therapy for Acute Lymphoblastic Leukemia,